JAK Inhibitor and Type I Interferon Possible Treatments for COVID-19
Study authors conducted a systematic review and meta-analysis to assess the efficacy of Janus kinase-inhibitors and Type I interferons as potential antiviral candidates for the treatment of COVID-19.